Any current/future new fundraising through debt or equity?

The transcript does not explicitly mention any current or planned fundraising through debt or equity. Rajit Mehta talks about a strong balance sheet with treasury and other assets standing at Rs. 500 crores as of December 2023, indicating healthy liquidity. There is mention of capital allocation for new business expansion, such as approximately Rs. 43 crores spent on AGEasy in FY24, with plans for further capital deployment next year. The discussion highlights ongoing investments and expansions (care homes, residences, digital business) funded from internal accruals and strong financial positi

Any current/future capex/capital investment/strategic investment?

Significant capital investment in AGEasy, with Rs. 43 crores spent in FY24, and plans for further capital allocation in FY25 to launch additional chronic conditions such as hearing loss, respiratory ailments, and diabetes. Ongoing investment in residential development projects, including: - Hyderabad: Largest development with about 748 units in two phases (1.3 million sq ft), with due diligence and closing expected soon. - Noida Phase-2: Development plans submitted; pricing and approvals under progress. - New cities: Definitive agreements signed for Gurgaon, Bangalore, and Hydera

Future growth expectations in sales/revenue/volumes?

FY25 forward-looking statements are cautious; clear aspirations for more care homes, residences, and business growth were shared but without specific targets (Page 12). By FY29, projected topline revenue is approximately Rs. 750 to Rs. 850 crores from senior living residences, DM fees, and profit shares (Page 11). Care At Home showed 45% YoY revenue growth in Q3 FY24, driven by high margin services and new geographies like Bangalore and Chennai (Page 6, 9). Medcare recorded 170% YoY net revenue growth in Q3 FY24; contribution margins expected to stabilize with private label product expansion (

Future growth expectations in earnings/operating earnings/profits/EPS?

FY25 forward-looking statements on specific earnings/profit targets are not provided due to the company's process but aspirations include growth in care homes, residences, and new business lines (Ajay Agrawal, Page 12). By FY29, turnover topline is expected between Rs. 750-850 crores from senior living including annuity income and share of profits (Ajay Agrawal, Page 11). Contribution margins for Care Homes expected at 20%+ when occupancy reaches around 70%; breakeven at 45% occupancy within 4 quarters (Ishaan Khanna, Page 9). Care At Home has shown strong growth (45% YoY revenue growth)

Current/ Expected Orderbook/ Pending Orders?

For Noida Phase-2 project, discussions and approvals with RERA are ongoing; definitive agreements executed for Gurgaon and Bangalore projects. Architectural massing, designing, and marketing strategies for Gurgaon completed; definitive agreement closed for Bangalore, awaiting final clearances. Term sheets executed for senior living residences in Gurugram, Bangalore, and Hyderabad, with due diligence ongoing for Hyderabad. Active discussions underway with landowners in Chandigarh, Goa, and Pune, aiming to close deals within a few months. Target to develop 1.5 million square feet annually. For A

Max India LtdQ3 FY24Finance

Max India Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹163Market Cap: ₹917 CrSector: Finance

Management growth scorecard

Revenue

Category 3

Margin

Category 5

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

FY25 forward-looking statements are cautious; clear aspirations for more care homes, residences, and business growth were shared but without specific targets (Page 12).
By FY29, projected topline revenue is approximately Rs. 750 to Rs. 850 crores from senior living residences, DM fees, and profit shares (Page 11).
Care At Home showed 45% YoY revenue growth in Q3 FY24, driven by high margin services and new geographies like Bangalore and Chennai (Page 6, 9).
Medcare recorded 170% YoY net revenue growth in Q3 FY24; contribution margins expected to stabilize with private label product expansion (Page 6).
AGEasy, a new phygital platform launched August 2023, quickly scaled to Rs. 1 crore revenue in Q3 FY24, with plans to launch in 8-10 cities physically, leveraging strong repeat customers and digital presence (Page 6, 12).
Overall strategic growth expected through expansion to 8-10 senior living communities across top Indian cities with 1,500-2,000 care home beds (Page 12).

Margin guidance

Category 5

FY25 forward-looking statements on specific earnings/profit targets are not provided due to the company's process but aspirations include growth in care homes, residences, and new business lines (Ajay Agrawal, Page 12).
By FY29, turnover topline is expected between Rs. 750-850 crores from senior living including annuity income and share of profits (Ajay Agrawal, Page 11).
Contribution margins for Care Homes expected at 20%+ when occupancy reaches around 70%; breakeven at 45% occupancy within 4 quarters (Ishaan Khanna, Page 9).
Care At Home has shown strong growth (45% YoY revenue growth) with projected doubling timeline inline with FY25 targets (Rajit Mehta, Pages 7-8).
Earnings in some segments like Medcare are still stabilizing, and EBITDA losses expected to continue in near term due to strategic investments (Page 6).
Focus on scaling business, customer satisfaction, and repeat revenues are expected to drive long-term growth (Page 12).

See what Max India Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

The transcript does not explicitly mention any current or planned fundraising through debt or equity.
Rajit Mehta talks about a strong balance sheet with treasury and other assets standing at Rs. 500 crores as of December 2023, indicating healthy liquidity.
There is mention of capital allocation for new business expansion, such as approximately Rs. 43 crores spent on AGEasy in FY24, with plans for further capital deployment next year.
The discussion highlights ongoing investments and expansions (care homes, residences, digital business) funded from internal accruals and strong financial position.
No direct statements about raising funds through fresh debt or equity were made during the call or in the transcript.

Order book

For Noida Phase-2 project, discussions and approvals with RERA are ongoing; definitive agreements executed for Gurgaon and Bangalore projects.
Architectural massing, designing, and marketing strategies for Gurgaon completed; definitive agreement closed for Bangalore, awaiting final clearances.
Term sheets executed for senior living residences in Gurugram, Bangalore, and Hyderabad, with due diligence ongoing for Hyderabad.
Active discussions underway with landowners in Chandigarh, Goa, and Pune, aiming to close deals within a few months.
Target to develop 1.5 million square feet annually.
For Assisted Care, 210 beds expected to be operational by March 2024, with plans for about 700 beds by FY25.
Letters of intent signed for additional beds; fit-outs are in progress.
There is a waitlist (pending order) for Noida Phase-2, with pricing to be decided based on market conditions.

See what Max India Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Significant capital investment in AGEasy, with Rs. 43 crores spent in FY24, and plans for further capital allocation in FY25 to launch additional chronic conditions such as hearing loss, respiratory ailments, and diabetes.
Ongoing investment in residential development projects, including:
- Hyderabad: Largest development with about 748 units in two phases (1.3 million sq ft), with due diligence and closing expected soon.
- Noida Phase-2: Development plans submitted; pricing and approvals under progress.
- New cities: Definitive agreements signed for Gurgaon, Bangalore, and Hyderabad residences; discussions ongoing for Chandigarh, Goa, Pune.
Expansion of Antara Assisted Care Services: increasing care home beds from 68 operational to about 700 by FY25 with fit-outs underway in Bangalore and Noida.
Building 8 to 10 senior living communities across top cities, targeting 1,500 to 2,000 care home beds.
Capital is being deployed to scale up residences, care homes, and new businesses in expansion mode.

Track Max India Ltd — get its next earnings analysis in your feed

How does Max India Ltd rank vs peers in Finance?

Pro feature

ThisMax India Ltd

Rev 3Mar 5

See where Max India Ltd sits in FinanceSee which companies these are, and every other name in the sector.Open rankings

How does Max India Ltd rank in Finance?

Compare Max India Ltd against every Finance company (Q3 FY24) on revenue, margins and earnings-call signals.

View Finance leaderboard →

What Max India Ltd's management said in earlier quarters

Others in Finance this season

SRG Housing Finance Ltd (Q1 FY27)
Profit after tax has shown strong growth of 33% in the financial year 2025-2026 and 25% in the recent quarter, indicating upward momentum. Key concall…
Moneyboxx Finance Ltd (Q1 FY27)
Monthly debt requirement around INR80 crores will continue to support disbursements and growth. Key concall takeaways from Moneyboxx Finance Ltd's Q1 FY27…
Nisus Finance Services Co Ltd (Q1 FY27)
Q1 FY27 Consolidated Revenue:** ₹184.49 Cr, up from ₹28.40 Cr in Q1 FY26 (approx. Key investor presentation takeaways from Nisus Finance Services Co Ltd's Q1 FY
CRISIL Ltd (Q2 FY25)
Q3 2024 Income from operations: ₹811.8 crore, up 10.3% YoY (Page 12) . Key concall takeaways from CRISIL Ltd's Q2 FY25 earnings call — and how it ranks against…

Compare:vs Bajaj Finserv vs Tata Capital vs Cholaman.Inv.&Fn

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →